vasopressin analogue

Terlipressin companies

Answer

Public registers name 5 licence holders, 7 bulk ingredient labelers, 2 US labelers, 55 trial sponsors and 1 recalling firm for Terlipressin.

Each row is what a register states. A company named here is not endorsed or accused by this site.

MARKETING AUTHORISATION HOLDER

5 companies

Holds the licence to sell the medicine in a country (EMA, MHRA, Health Canada).

AFT PHARMA UK LIMITED
TERLIPRESSIN ACETATE AFT 0.12 MG/ML SOLUTION FOR INJECTION, PL 57592/0008, Authorised Regulator MHRA
EVER VALINJECT GMBH
TERLIPRESSIN ACETATE EVER PHARMA 0.2 MG/ML SOLUTION FOR INJECTION, PL 46654/0004, Authorised Regulator MHRA
FARMAK PHARMACEUTICALS UK LTD
TERLIPRESSIN ACETATE 0.12 MG/ML SOLUTION FOR INJECTION, PL 59209/0018, Authorised Regulator MHRA
TERLIPRESSIN ACETATE 0.2 MG/ML, SOLUTION FOR INJECTION, PL 59209/0019, Authorised Regulator MHRA
FERRING PHARMACEUTICALS LIMITED
TERLIPRESSIN ACETATE 0.12 MG/ML, SOLUTION FOR INJECTION, PL 03194/0101, Authorised Regulator MHRA
TERLIPRESSIN ACETATE 1MG, POWDER AND SOLVENT FOR SOLUTION FOR INJECTION, PL 03194/0018, Authorised Regulator MHRA
SUN PHARMACEUTICAL INDUSTRIES EUROPE BV
TERLIPRESSIN ACETATE SUN 0.12 MG/ML SOLUTION FOR INJECTION, PL 31750/0052, Authorised Regulator MHRA

BULK INGREDIENT LABELER

7 companies

Lists the bulk active ingredient with FDA (NDC directory).

BCN PEPTIDES SA
Terlipressin, BULK INGREDIENT Regulator openFDA
Chengdu Shengnuo Biopharm Co. Ltd.
Terlipressin Acetate, BULK INGREDIENT Regulator openFDA
Hemmo Pharmaceuticals Pvt. Ltd
Terlipressin, BULK INGREDIENT Regulator openFDA
Hybio Pharmaceutical Co., Ltd.
Terlipressin Acetate, BULK INGREDIENT Regulator openFDA
Piramal Pharma Limited
Terlipressin, BULK INGREDIENT Regulator openFDA
Polypeptide Laboratories (Sweden) AB
Terlipressin, BULK INGREDIENT Regulator openFDA
Polypeptide Laboratories San Diego, LLC
TERLIPRESSIN, BULK INGREDIENT Regulator openFDA

US LABELER

2 companies

Lists a finished product with FDA (NDC directory); can be a maker, repackager or distributor.

Mallinckrodt Hospital Products Inc.
Terlivaz, NDA Regulator openFDA
Patheon Italia S.p.A
terlipressin, DRUG FOR FURTHER PROCESSING Regulator openFDA

TRIAL SPONSOR

55 companies

Sponsors registered clinical trials of the peptide.

Institute of Liver and Biliary Sciences, India
13 registered trials Trial register ClinicalTrials.gov
Post Graduate Institute of Medical Education and Research, Chandigarh
4 registered trials Trial register ClinicalTrials.gov
Shanghai Zhongshan Hospital
4 registered trials Trial register ClinicalTrials.gov
Wael Elbanna Clinic
4 registered trials Trial register ClinicalTrials.gov
Aga Khan University
3 registered trials Trial register ClinicalTrials.gov
Assiut University
3 registered trials Trial register ClinicalTrials.gov
First Affiliated Hospital, Sun Yat-Sen University
3 registered trials Trial register ClinicalTrials.gov
General Hospital of Shenyang Military Region
3 registered trials Trial register ClinicalTrials.gov
Hospital Clinic of Barcelona
3 registered trials Trial register ClinicalTrials.gov
Mallinckrodt
3 registered trials Trial register ClinicalTrials.gov
Assistance Publique - Hôpitaux de Paris
2 registered trials Trial register ClinicalTrials.gov
Ferring Pharmaceuticals
2 registered trials Trial register ClinicalTrials.gov
Hvidovre University Hospital
2 registered trials Trial register ClinicalTrials.gov
National Science and Technology Council, Taiwan
2 registered trials Trial register ClinicalTrials.gov
River 2 Renal Corp.
1 registered trial Trial register EU CTIS
1 registered trial Trial register ClinicalTrials.gov
University of Padova
2 registered trials Trial register ClinicalTrials.gov
University of Roma La Sapienza
2 registered trials Trial register ClinicalTrials.gov
Amany Mousa Salama Muhammed
1 registered trial Trial register ClinicalTrials.gov
Assaf-Harofeh Medical Center
1 registered trial Trial register ClinicalTrials.gov
Assistance Publique Hopitaux De Marseille
1 registered trial Trial register ClinicalTrials.gov
Assistance Publique Hopitaux De Paris
1 registered trial Trial register EU CTIS
Beijing Friendship Hospital
1 registered trial Trial register ClinicalTrials.gov
Beijing Tsinghua Chang Gung Hospital
1 registered trial Trial register ClinicalTrials.gov
BioVie Inc.
1 registered trial Trial register ClinicalTrials.gov
Changhai Hospital
1 registered trial Trial register ClinicalTrials.gov
E-DA Hospital
1 registered trial Trial register ClinicalTrials.gov
Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevilla
1 registered trial Trial register EU CTIS
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
1 registered trial Trial register ClinicalTrials.gov
Hospital General de Ciudad Real
1 registered trial Trial register ClinicalTrials.gov
Insel Gruppe AG, University Hospital Bern
1 registered trial Trial register ClinicalTrials.gov
Instituto Mexicano del Seguro Social
1 registered trial Trial register ClinicalTrials.gov
Istanbul Medipol University Hospital
1 registered trial Trial register ClinicalTrials.gov
Juan A. Arnaiz
1 registered trial Trial register ClinicalTrials.gov
Kaohsiung Veterans General Hospital.
1 registered trial Trial register ClinicalTrials.gov
Kasr El Aini Hospital
1 registered trial Trial register ClinicalTrials.gov
Korea University
1 registered trial Trial register ClinicalTrials.gov
Lahore General Hospital
1 registered trial Trial register ClinicalTrials.gov
Liu ZiMeng
1 registered trial Trial register ClinicalTrials.gov
Mahidol University
1 registered trial Trial register ClinicalTrials.gov
Nanfang Hospital, Southern Medical University
1 registered trial Trial register ClinicalTrials.gov

Showing 40 of 55.

RECALLING FIRM

1 company

Recalled a product naming the peptide (FDA enforcement report).

Mallinckrodt Hospital Products Inc.
Class II recall, Ongoing, 2024-02-28 Regulator openFDA

Every company across all peptides: companies. Names are matched only when identical apart from case and punctuation, so one group can appear under two spellings.

WEEKLY

Register Watch, weekly

New trials, approvals and enforcement actions. One email a week.